Koch A - Search Results

1

Comparison of MRI and VQ-SPECT as a Screening Test for Patients With Suspected CTEPH: CHANGE-MRI Study Design and Rationale.

Lasch F, Karch A, Koch A, Derlin T, Voskrebenzev A, Alsady TM, Hoeper MM, Gall H, Roller F, Harth S, Steiner D, Krombach G, Ghofrani HA, Rengier F, Heußel CP, Grünig E, Beitzke D, Hacker M, Lang IM, Behr J, Bartenstein P, Dinkel J, Schmidt KH, Kreitner KF, Frauenfelder T, Ulrich S, Hamer OW, Pfeifer M, Johns CS, Kiely DG, Swift AJ, Wild J, Vogel-Claussen J. Lasch F, et al. Among authors: koch a. Front Cardiovasc Med. 2020 Apr 9;7:51. doi: 10.3389/fcvm.2020.00051. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 32328500 Free PMC article.

2

Respiratory tract exacerbations revisited: ventilation, inflammation, perfusion, and structure (VIPS) monitoring to redefine treatment.

Tiddens HA, Stick SM, Wild JM, Ciet P, Parker GJ, Koch A, Vogel-Claussen J. Tiddens HA, et al. Among authors: koch a. Pediatr Pulmonol. 2015 Oct;50 Suppl 40:S57-65. doi: 10.1002/ppul.23266. Pediatr Pulmonol. 2015. PMID: 26335955 Review.

3

Non-invasive diagnosis of acute rejection in renal transplant patients using mass spectrometry of urine samples - a multicentre phase 3 diagnostic accuracy study.

Zapf A, Gwinner W, Karch A, Metzger J, Haller H, Koch A. Zapf A, et al. Among authors: koch a. BMC Nephrol. 2015 Sep 15;16:153. doi: 10.1186/s12882-015-0146-x. BMC Nephrol. 2015. PMID: 26374548 Free PMC article. Clinical Trial.

4

Direct and indirect costs of COPD and its comorbidities: Results from the German COSYCONET study.

Wacker ME, Jörres RA, Schulz H, Heinrich J, Karrasch S, Karch A, Koch A, Peters A, Leidl R, Vogelmeier C, Holle R; COSYCONET-Consortium. Wacker ME, et al. Among authors: koch a. Respir Med. 2016 Feb;111:39-46. doi: 10.1016/j.rmed.2015.12.001. Epub 2015 Dec 10. Respir Med. 2016. PMID: 26725462 Free article.

5

Partial verification bias and incorporation bias affected accuracy estimates of diagnostic studies for biomarkers that were part of an existing composite gold standard.

Karch A, Koch A, Zapf A, Zerr I, Karch A. Karch A, et al. Among authors: koch a. J Clin Epidemiol. 2016 Oct;78:73-82. doi: 10.1016/j.jclinepi.2016.03.022. Epub 2016 Apr 21. J Clin Epidemiol. 2016. PMID: 27107877

6

Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities.

Wacker ME, Jörres RA, Karch A, Wilke S, Heinrich J, Karrasch S, Koch A, Schulz H, Watz H, Leidl R, Vogelmeier C, Holle R; COSYCONET-Consortium. Wacker ME, et al. Among authors: koch a. BMC Pulm Med. 2016 May 10;16(1):70. doi: 10.1186/s12890-016-0238-9. BMC Pulm Med. 2016. PMID: 27160582 Free PMC article.

7

A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial.

Karch A, Koch A, Grünwald V. Karch A, et al. Among authors: koch a. Trials. 2016 Jul 7;17(1):312. doi: 10.1186/s13063-016-1434-x. Trials. 2016. PMID: 27387325 Free PMC article. Clinical Trial.

8

Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies.

Wacker ME, Jörres RA, Karch A, Koch A, Heinrich J, Karrasch S, Schulz H, Peters A, Gläser S, Ewert R, Baumeister SE, Vogelmeier C, Leidl R, Holle R; COSYCONET study group. Wacker ME, et al. Among authors: koch a. Respir Res. 2016 Jul 12;17(1):81. doi: 10.1186/s12931-016-0401-0. Respir Res. 2016. PMID: 27405652 Free PMC article.

9

Peripheral Artery Disease and Its Clinical Relevance in Patients with Chronic Obstructive Pulmonary Disease in the COPD and Systemic Consequences-Comorbidities Network Study.

Houben-Wilke S, Jörres RA, Bals R, Franssen FM, Gläser S, Holle R, Karch A, Koch A, Magnussen H, Obst A, Schulz H, Spruit MA, Wacker ME, Welte T, Wouters EF, Vogelmeier C, Watz H. Houben-Wilke S, et al. Among authors: koch a. Am J Respir Crit Care Med. 2017 Jan 15;195(2):189-197. doi: 10.1164/rccm.201602-0354OC. Am J Respir Crit Care Med. 2017. PMID: 27532739

10

A plea to provide best evidence in trials under sample-size restrictions: the example of pioglitazone to resolve leukoplakia and erythroplakia in Fanconi anemia patients.

Lasch F, Weber K, Chao MM, Koch A. Lasch F, et al. Among authors: koch a. Orphanet J Rare Dis. 2017 May 25;12(1):102. doi: 10.1186/s13023-017-0655-8. Orphanet J Rare Dis. 2017. PMID: 28545482 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,047 results

Search Page

Filters